US 11352389
Treatment of haematological malignancies
granted A61KA61K2039/525A61K2039/53
Quick answer
US patent 11352389 (Treatment of haematological malignancies) held by Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/525, A61K2039/53, A61K2039/572, A61K2039/585